<DOC>
	<DOCNO>NCT01049009</DOCNO>
	<brief_summary>High blood pressure ( hypertension ) call `` silent killer '' many people know , know well control . Unfortunately , time uncontrolled hypertension cause irreversible organ damage lead heart attack , stroke , heart failure , kidney failure . If person control blood pressure diet exercise , doctor often prescribe medication help control blood pressure . Nebivolol medication recently approve FDA treatment hypertension . Our study investigate whether treatment nebivolol , compare another medication call metoprolol , African Americans hypertension effective protect blood vessel harmful effect high blood pressure . Over time high blood pressure cause harden artery ( atherosclerosis ) lead narrow blood vessel reduce blood flow organ . Arteries also relax contract naturally , change blood supply . When artery narrow , exercise bring condition blood supply inadequate , might result sensation pain . Cells line blood vessel produce variety substance normally cause artery relax . Two substance call nitric oxide ( NO ) endothelium-derived hyperpolarizing factor ( EDHF ) . We try determine nature substance African Americans high blood pressure affect nebivolol metoprolol . One way determine inject drug L-NMMA ( N ( G ) -monomethyl-L-arginine ) TEA ( tetraethylammonium chloride ) , block production NO EDHF respectively , study happen blood flow rest exercise . It think nebivolol , comparison metoprolol , increase substance naturally cause artery relax improve blood supply .</brief_summary>
	<brief_title>The Effect Nebivolol Endothelial Dysfunction African Americans With Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Nebivolol</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<mesh_term>Endothelium-Dependent Relaxing Factors</mesh_term>
	<criteria>Male postmenopausal female age 1880 year . Subjects selfidentified black AfricanAmerican . Diagnosis hypertension . Patients current antihypertensive therapy include beta blockade BP &gt; 135/85 . Patients antihypertensive therapy include beta blocker beta blocker discontinue gradually 2 week enrolment . Concomitant therapy : Patients allow concomitant therapy aspirin , statin , thiazide diuretic , calcium antagonist ( treatment hypertension ) , clonidine , vasodilator . Patients stable medical therapy least 2 month recruitment . Patients previous treatment beta adrenergic blocker ( metoprolol , propranolol , atenolol , labetalol ) also eligible participate , randomize study beta blocker . Initiation change dose statin antihypertensive therapy within 2 month study Inability return Emory followup test Age &lt; 21 &gt; 80 year Premenopausal females potential pregnancy Acute infection previous 2 week On angiotensin antagonist ( ACE inhibitor ARBs ) History substance abuse Current neoplasm Chronic renal failure [ creatinine &gt; 2.5 mg/dL ] liver failure ( liver enzymes &gt; 2X normal ) Acute coronary syndrome , Class IV heart failure , CVA , coronary intervention within 2 month Known aortic stenosis , hypertrophic cardiomyopathy . Inability give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Nitric Oxide</keyword>
	<keyword>Adrenergic beta-Antagonists</keyword>
	<keyword>Antihypertensive Agents</keyword>
	<keyword>Vasodilator Agents</keyword>
	<keyword>Anti-Arrhythmia Agents</keyword>
	<keyword>Sympatholytics</keyword>
	<keyword>Vascular Resistance</keyword>
	<keyword>Neurotransmitter Agents</keyword>
	<keyword>Cardiovascular Diseases</keyword>
	<keyword>Metoprolol succinate</keyword>
	<keyword>Therapeutic Uses</keyword>
	<keyword>Metoprolol</keyword>
	<keyword>Vascular Diseases</keyword>
	<keyword>Nebivolol</keyword>
	<keyword>Cardiovascular Agents</keyword>
	<keyword>Endothelium-Dependent Relaxing Factors</keyword>
</DOC>